Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...
Creative Diagnostics has announced its comprehensive Drug Discovery Services for antiviral therapeutic development. NEW YORK, NY, UNITED ST ...
The study demonstrates that this RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth - a ...
News Medical on MSN2d
ELRIG Announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025ELRIG, a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...
The company's first siRNA drug could be in the clinic by the end of 2026. Drug developers' dreams of silencing RNA as a way to step in front of a range of diseases have not lived up to early-day hype.
Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...
Home > Pressemitteilung: Major Progress in the Development of ...
Researchers at Martin Luther University have developed groundbreaking RNA-based agents that offer high levels of protection ...
Novo Nordisk has signed a deal with AI-driven protein design company Gensaic to develop tissue-targeted therapies for cardiometabolic diseases. The collaboration is valued up to $354m, but ...
SAN FRANCISCO, CA, USA I March 13, 2025 I Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback